Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids.
Published December 14, 2016 · Recall initiated: November 10, 2016
Summary
FDA records medical device Class III recall Z-0722-2017, published December 14, 2016 and initiated November 10, 2016. Recalling firm: OraSure Technologies, Inc.; Status: Terminated; Reported quantity: 4 kits; Lot: Lot # 6654085. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- OraSure Technologies, Inc.
- Distributor
- Distributed to KS, and VA
- Lot
- Lot # 6654085
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDARayStation 4.0, 4.5, 4.7 and 5.0; Radiation Therapy Treatment Planning System Product Usage: RayStation is aDecember 14, 2016
- FDAADVIA 560 Hematology Systems, Siemens Material Number (SMN) 11170842, IVD.December 14, 2016
- FDAPerceval Sutureless Aortic Heart Valve size S, Item # ICV1208, REF PVS21; Perceval Sutureless Aortic HeartDecember 14, 2016
- FDAHalyard C-Section Drape with Clear Screen and Full Incise (Non-Sterile), Product Code 44965 NS; C-SectionDecember 14, 2016
- FDAPeripherally Inserted Central Catheters (PICC), UPN H965750141, Catalog # 75-014 The Maximal Barrier NursingDecember 14, 2016
- FDAMagnesium on RX Imola analyser IVDDecember 14, 2016
Questions about this recall
Was Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids. recalled?
Yes. FDA published recall Z-0722-2017 on December 14, 2016. Reported hazard: Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone